Min Chung

A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy

Sun Jin Sym, Junshik Hong, Jinny Park et al. · Cancer Chemotherapy and Pharmacology · 2012 · 81 citations

Medicine, Oncology, Pharmacology +15

D1A, D1B, and D1C dopamine receptors from Xenopus laevis.

Kim S. Sugamori, Lidia Demchyshyn, Min Chung et al. · Proceedings of the National Academy of Sciences · 1994 · 66 citations

Medicine, Neurobiology, Pharmacology +15

Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil

Se Hoon Park, Woon Kee Lee, Min Chung et al. · Anti-Cancer Drugs · 2006 · 58 citations

Medicine, Oncology, Pharmacology +17

Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination chemotherapy for advanced gastric cancer

So-Min Park, Eunmi Nam, Jinny Park et al. · Annals of Oncology · 2007 · 42 citations · Full text

Medicine, Oncology, Pharmacology +14

Inhibition of myogenesis by okadaic acid, an inhibitor of protein phosphatases, 1 and 2A, correlates with the induction of AP1.

K Park, Min Chung, S.J. Kim · Journal of Biological Chemistry · 1992 · 36 citations · Full text

Life Sciences, Biochemistry, Cell Biology +9